Carsten Niemann

Carsten Niemann

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
1 - 10 out of 21Page size: 10
  1. 2022
  2. Published

    Artificial intelligence models in chronic lymphocytic leukemia–recommendations toward state-of-the-art

    Agius, R., Parviz, M. & Niemann, Carsten, 2022, In: Leukemia and Lymphoma. 63, 2, p. 265-278 14 p.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia

    Andersen, M. A., Grand, Mia Klinten, Brieghel, C., Siersma, Volkert Dirk, Andersen, Christen Bertel L & Niemann, Carsten, 2022, In: Communications Medicine. 2, 8 p., 50.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

    Brieghel, C., Galle, V., Agius, R., da Cunha-Bang, C., Andersen, M. A., Vlummens, P., Mattsson, M., Rosenquist, R., Smedby, K. E., Herling, C. D., Bahlo, J., Hallek, M., Lundgren, Jens, Offner, F. & Niemann, Carsten, 2022, In: European Journal of Haematology. 108, 5, p. 369-378 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    The gut microbiome in patients with chronic lymphocytic leukemia

    Faitová, T., Svanberg, R., Da Cunha-Bang, C., Ilett, E. E., Jørgensen, M., Noguera-Julian, M., Paredes, R., MacPherson, C. R. & Niemann, Carsten, 2022, In: Haematologica. 107, 9, p. 2238-2243 6 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  6. Published

    Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21(R110)

    Hengeveld, P. J., Ertem, Y. E., Dubois, J. M. N., Mellink, C. H. M., van der Kevie-kersemaekers, A., Evers, L. M., Heezen, K., Kolijn, P. M., Mook, O. R. F., Motazacker, M. M., Nasserinejad, K., Kersting, S., Westerweel, P. E., Niemann, Carsten, Kater, A. P., Langerak, A. W. & Levin, M., 2022, In: Leukemia. 36, 7, p. 1935-1938 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  7. Published

    Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia

    Huber, H., Edenhofer, S., von Tresckow, J., Robrecht, S., Zhang, C., Tausch, E., Schneider, C., Bloehdorn, J., Fürstenau, M., Dreger, P., Ritgen, M., Illmer, T., Illert, A. L., Dürig, J., Böttcher, S., Niemann, C. U., Kneba, M., Fink, A-M., Fischer, K., Döhner, H. & 3 others, Hallek, M., Eichhorst, B. & Stilgenbauer, S., 2022, In: Blood. 139, 9, p. 1318-1329 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL

    Husby, Simon, Bæch-Laursen, C., Eskelund, C. W., Favero, Francesco, Jespersen, Jakob Schmidt, Hutchings, M., Pedersen, L. B., Niemann, Carsten, Weischenfeldt, Joachim Lütken, Räty, R., Larsen, T. S., Kolstad, A., Jerkeman, M. & Grønbæk, Kirsten, 2022, In: Leukemia. 36, p. 2912-2916

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Chest x-ray imaging score is associated with severity of COVID-19 pneumonia: the MBrixia score

    Jensen, C. M., Costa, J. C., Nørgaard, J. C., Zucco, Adrian G., Neesgaard, B., Niemann, Carsten, Ostrowski, Sisse Rye, Reekie, J., Holten, B., Kalhauge, A., Matthay, M. A., Lundgren, Jens, Helleberg, Marie & Moestrup, K. S., 2022, In: Scientific Reports. 12, 21019.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial

    Kater, A. P., Levin, M. D., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., van der Kevie-Kersemaekers, A. M. F., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Brieghel, C., Mattsson, M., Bellido, M., Tran, H. T. T. & 2 others, Nasserinejad, K. & Niemann, Carsten, 2022, In: The Lancet Oncology. 23, 6, p. 818-828 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

    Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, Anne Ortved, Enggaard, L., Hansen, M., Holmström, M. O., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2022, In: Frontiers in Oncology. 12, 1023015.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 185059285